Pfizer, Moderna expect $51B in vaccine sales in 2022

Pfizer and Moderna are expecting $32 billion and $19 billion, respectively, in COVID-19 vaccine sales this year, CNBC reported March 3.

The expectations are based on fourth-quarter earnings statements the companies released this month.